{"id":"https://openalex.org/W4389220840","doi":"https://doi.org/10.1182/blood-2023-178872","title":"A Phase 1 Dose Escalation Trial of Third-Generation CD19-Directed CAR T-Cells Incorporating CD28 and Toll-like Receptor 2 (TLR2) Intracellular Domains for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (ENABLE)","display_name":"A Phase 1 Dose Escalation Trial of Third-Generation CD19-Directed CAR T-Cells Incorporating CD28 and Toll-like Receptor 2 (TLR2) Intracellular Domains for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (ENABLE)","publication_year":2023,"publication_date":"2023-11-02","ids":{"openalex":"https://openalex.org/W4389220840","doi":"https://doi.org/10.1182/blood-2023-178872"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2023-178872","doi":"https://doi.org/10.1182/blood-2023-178872","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2023-178872","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001620682","display_name":"Robert Weinkove","orcid":"https://orcid.org/0000-0003-3645-7988","observed_orcids":["https://orcid.org/0000-0003-3645-7988","https://orcid.org/0000-0002-7635-3350"]},"institutions":[{"id":"https://openalex.org/I200359443","display_name":"Malaghan Institute of Medical Research","ror":"https://ror.org/02487ts63","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I200359443"]},{"id":"https://openalex.org/I4405259026","display_name":"Health New Zealand","ror":"https://ror.org/01jvwvd85","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Robert Weinkove","raw_affiliation_strings":["1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand","2Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand","institution_ids":["https://openalex.org/I200359443"]},{"raw_affiliation_string":"2Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand","institution_ids":["https://openalex.org/I4405259026"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Philip George","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200359443","display_name":"Malaghan Institute of Medical Research","ror":"https://ror.org/02487ts63","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I200359443"]},{"id":"https://openalex.org/I4405259026","display_name":"Health New Zealand","ror":"https://ror.org/01jvwvd85","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Philip George","raw_affiliation_strings":["1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand","2Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand","institution_ids":["https://openalex.org/I200359443"]},{"raw_affiliation_string":"2Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand","institution_ids":["https://openalex.org/I4405259026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093393926","display_name":"Robert Fyfe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200359443","display_name":"Malaghan Institute of Medical Research","ror":"https://ror.org/02487ts63","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I200359443"]},{"id":"https://openalex.org/I4405259026","display_name":"Health New Zealand","ror":"https://ror.org/01jvwvd85","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Robert Fyfe","raw_affiliation_strings":["1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand","2Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand","institution_ids":["https://openalex.org/I200359443"]},{"raw_affiliation_string":"2Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand","institution_ids":["https://openalex.org/I4405259026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017273435","display_name":"Nathaniel Dasyam","orcid":"https://orcid.org/0000-0002-2929-0270","observed_orcids":["https://orcid.org/0000-0002-2929-0270"]},"institutions":[{"id":"https://openalex.org/I200359443","display_name":"Malaghan Institute of Medical Research","ror":"https://ror.org/02487ts63","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I200359443"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Nathaniel Dasyam","raw_affiliation_strings":["1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand","institution_ids":["https://openalex.org/I200359443"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085759793","display_name":"Yasmin Nouri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I196021976","display_name":"Walter and Eliza Hall Institute of Medical Research","ror":"https://ror.org/01b6kha49","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I196021976"]},{"id":"https://openalex.org/I200359443","display_name":"Malaghan Institute of Medical Research","ror":"https://ror.org/02487ts63","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I200359443"]}],"countries":["AU","NZ"],"is_corresponding":false,"raw_author_name":"Yasmin Nouri","raw_affiliation_strings":["1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand","3Division of Immunology, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand","institution_ids":["https://openalex.org/I200359443"]},{"raw_affiliation_string":"3Division of Immunology, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia","institution_ids":["https://openalex.org/I196021976"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033178537","display_name":"Tess Ostapowicz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200359443","display_name":"Malaghan Institute of Medical Research","ror":"https://ror.org/02487ts63","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I200359443"]},{"id":"https://openalex.org/I4405259026","display_name":"Health New Zealand","ror":"https://ror.org/01jvwvd85","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Tess Ostapowicz","raw_affiliation_strings":["1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand","4Clinical Trials Unit, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand","institution_ids":["https://openalex.org/I200359443"]},{"raw_affiliation_string":"4Clinical Trials Unit, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand","institution_ids":["https://openalex.org/I4405259026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093393927","display_name":"Stefan Mullins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200359443","display_name":"Malaghan Institute of Medical Research","ror":"https://ror.org/02487ts63","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I200359443"]},{"id":"https://openalex.org/I4405259026","display_name":"Health New Zealand","ror":"https://ror.org/01jvwvd85","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Stefan Mullins","raw_affiliation_strings":["1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand","2Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand","institution_ids":["https://openalex.org/I200359443"]},{"raw_affiliation_string":"2Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand","institution_ids":["https://openalex.org/I4405259026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029987163","display_name":"Brigitta Mester","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200359443","display_name":"Malaghan Institute of Medical Research","ror":"https://ror.org/02487ts63","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I200359443"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Brigitta Mester","raw_affiliation_strings":["1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand","institution_ids":["https://openalex.org/I200359443"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Giulia Giunti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200359443","display_name":"Malaghan Institute of Medical Research","ror":"https://ror.org/02487ts63","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I200359443"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Giulia Giunti","raw_affiliation_strings":["5Clinical Human Immunology Laboratory, Malaghan Institute of Medical Research, Wellington, New Zealand","6BioOra, Wellington, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Clinical Human Immunology Laboratory, Malaghan Institute of Medical Research, Wellington, New Zealand","institution_ids":["https://openalex.org/I200359443"]},{"raw_affiliation_string":"6BioOra, Wellington, New Zealand","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006134549","display_name":"Catherine M. Bollard","orcid":"https://orcid.org/0000-0001-5140-9090","observed_orcids":["https://orcid.org/0000-0001-5140-9090"]},"institutions":[{"id":"https://openalex.org/I1336742384","display_name":"Children's National","ror":"https://ror.org/03wa2q724","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336742384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine M. Bollard","raw_affiliation_strings":["7Children's National Hospital, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Children's National Hospital, Washington, DC","institution_ids":["https://openalex.org/I1336742384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103796503","display_name":"Travis Perera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259026","display_name":"Health New Zealand","ror":"https://ror.org/01jvwvd85","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Travis Perera","raw_affiliation_strings":["2Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand","institution_ids":["https://openalex.org/I4405259026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082436863","display_name":"Hayden Jina","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259026","display_name":"Health New Zealand","ror":"https://ror.org/01jvwvd85","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Hayden Jina","raw_affiliation_strings":["2Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand","institution_ids":["https://openalex.org/I4405259026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110262442","display_name":"Alwyn D\u2019Souza","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405259026","display_name":"Health New Zealand","ror":"https://ror.org/01jvwvd85","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I4405259026"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Alwyn D'Souza","raw_affiliation_strings":["2Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand","institution_ids":["https://openalex.org/I4405259026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101441065","display_name":"Le Qin","orcid":"https://orcid.org/0000-0002-8244-8217","observed_orcids":["https://orcid.org/0000-0002-8244-8217"]},"institutions":[{"id":"https://openalex.org/I19820366","display_name":"Chinese Academy of Sciences","ror":"https://ror.org/034t30j35","country_code":"CN","type":"government","lineage":["https://openalex.org/I19820366"]},{"id":"https://openalex.org/I2802148028","display_name":"Guangzhou Institutes of Biomedicine and Health","ror":"https://ror.org/02c31t502","country_code":"CN","type":"facility","lineage":["https://openalex.org/I19820366","https://openalex.org/I2802148028"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Le Qin","raw_affiliation_strings":["8Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China","institution_ids":["https://openalex.org/I19820366","https://openalex.org/I2802148028"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David S. Ritchie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"David S. Ritchie","raw_affiliation_strings":["9Department of Medicine, The University of Melbourne, Parkville, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Department of Medicine, The University of Melbourne, Parkville, Australia","institution_ids":["https://openalex.org/I165779595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020199989","display_name":"Chris Miles Frampton","orcid":"https://orcid.org/0000-0003-0603-5661","observed_orcids":["https://orcid.org/0000-0003-0603-5661"]},"institutions":[{"id":"https://openalex.org/I80281795","display_name":"University of Otago","ror":"https://ror.org/01jmxt844","country_code":"NZ","type":"education","lineage":["https://openalex.org/I80281795"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Chris M.A. Frampton","raw_affiliation_strings":["10Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand","institution_ids":["https://openalex.org/I80281795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087604368","display_name":"Rachel Perret","orcid":"https://orcid.org/0000-0003-1225-5097","observed_orcids":["https://orcid.org/0000-0003-1225-5097"]},"institutions":[{"id":"https://openalex.org/I200359443","display_name":"Malaghan Institute of Medical Research","ror":"https://ror.org/02487ts63","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I200359443"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Rachel Perret","raw_affiliation_strings":["1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand","institution_ids":["https://openalex.org/I200359443"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100432789","display_name":"Peng Li","orcid":"https://orcid.org/0000-0003-4530-2400","observed_orcids":["https://orcid.org/0000-0003-4530-2400"]},"institutions":[{"id":"https://openalex.org/I19820366","display_name":"Chinese Academy of Sciences","ror":"https://ror.org/034t30j35","country_code":"CN","type":"government","lineage":["https://openalex.org/I19820366"]},{"id":"https://openalex.org/I2802148028","display_name":"Guangzhou Institutes of Biomedicine and Health","ror":"https://ror.org/02c31t502","country_code":"CN","type":"facility","lineage":["https://openalex.org/I19820366","https://openalex.org/I2802148028"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Peng Li","raw_affiliation_strings":["11Wellington Zhaotai Therapies Limited, Wellington, New Zealand","8Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Wellington Zhaotai Therapies Limited, Wellington, New Zealand","institution_ids":[]},{"raw_affiliation_string":"8Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China","institution_ids":["https://openalex.org/I19820366","https://openalex.org/I2802148028"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014939316","display_name":"Ian F. Hermans","orcid":"https://orcid.org/0000-0002-7584-887X","observed_orcids":["https://orcid.org/0000-0002-7584-887X"]},"institutions":[{"id":"https://openalex.org/I200359443","display_name":"Malaghan Institute of Medical Research","ror":"https://ror.org/02487ts63","country_code":"NZ","type":"healthcare","lineage":["https://openalex.org/I200359443"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Ian Hermans","raw_affiliation_strings":["1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand","institution_ids":["https://openalex.org/I200359443"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"142","issue":"Supplement 1","first_page":"890","last_page":"890"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd19-car-t-cell-therapy","display_name":"CD19 CAR T-cell therapy","score":0.8040000200271606},{"id":"https://openalex.org/keywords/cd28-costimulation","display_name":"CD28 costimulation","score":0.9129999876022339},{"id":"https://openalex.org/keywords/tlr2","display_name":"TLR2","score":0.8740000128746033},{"id":"https://openalex.org/keywords/4-1bb","display_name":"4-1BB","score":0.7680000066757202},{"id":"https://openalex.org/keywords/relapsed-or-refractory-b-cell-non-hodgkin-lymphoma","display_name":"relapsed or refractory B-cell non-Hodgkin lymphoma","score":0.9620000123977661},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7720000147819519},{"id":"https://openalex.org/keywords/immune-effector-cell-associated-neurotoxicity-syndrome","display_name":"immune effector cell-associated neurotoxicity syndrome","score":0.8420000076293945},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.9929999709129333},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.5820000171661377},{"id":"https://openalex.org/keywords/fludarabine-and-cyclophosphamide","display_name":"fludarabine and cyclophosphamide","score":0.8519999980926514},{"id":"https://openalex.org/keywords/car-t-cell-manufacturing","display_name":"CAR T cell manufacturing","score":0.4410000145435333}],"concepts":[{"id":"https://openalex.org/C148125776","wikidata":"https://www.wikidata.org/wiki/Q1622348","display_name":"CD28","level":4,"score":0.6598577499389648},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5734497904777527},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.5513807535171509},{"id":"https://openalex.org/C2780850621","wikidata":"https://www.wikidata.org/wiki/Q3961647","display_name":"Cytokine release syndrome","level":5,"score":0.5466615557670593},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42066699266433716},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.40725651383399963},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3807560205459595},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3738689124584198},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.34930992126464844},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.32059961557388306}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2023-178872","doi":"https://doi.org/10.1182/blood-2023-178872","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2023-178872","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4405045924","https://openalex.org/W3005561109","https://openalex.org/W4410803666","https://openalex.org/W4407863584","https://openalex.org/W4410795111","https://openalex.org/W7163425458","https://openalex.org/W4407976133","https://openalex.org/W2978812899","https://openalex.org/W2936551248","https://openalex.org/W3089727781"],"abstract_inverted_index":{"Introduction:":[0],"Chimeric":[1],"antigen":[2],"receptor":[3,83],"(CAR)":[4],"T":[5],"cell":[6,340],"therapies":[7],"directed":[8],"against":[9],"CD19":[10],"and":[11,57,90,99,116,128,142,156,222,237,242,257,272,280,362,380,426,443,452,477,554,600,617,655,675,680,683],"incorporating":[12],"either":[13],"CD28":[14,37,115,155,599,654],"or":[15,27,634],"4-1BB":[16,64],"intracellular":[17,110],"co-stimulatory":[18,158,602],"domains":[19,159,603,657],"are":[20],"a":[21,69,145,165,349,590,650,669,691],"standard":[22],"of":[23,50,108,124,133,144,172,253,338,351,355,385,410,448,455,524,560,574,589,614,649,685],"care":[24],"for":[25,71,181,278,303,604],"relapsed":[26],"refractory":[28],"(r/r)":[29],"B-cell":[30,185],"lymphomas.":[31],"CD19-directed":[32,149,593,638],"CAR":[33,72,121,150,177,209,239,245,304,370,515,531,538,555,594,628,660,687],"T-cell":[34,73,94,102,122,151,240,539,595,629],"products":[35,74],"employing":[36],"co-stimulation":[38],"yield":[39],"high":[40,77],"response":[41,507],"rates,":[42],"but":[43],"have":[44],"been":[45],"associated":[46],"with":[47,79,183,196,504,642],"higher":[48],"rates":[49],"immune":[51],"effector":[52],"cell-associated":[53],"neurotoxicity":[54],"syndrome":[55,61],"(ICANS)":[56],"severe":[58,610],"cytokine":[59,97,136],"release":[60],"(CRS)":[62],"than":[63,636],"co-stimulated":[65],"products.":[66,639],"There":[67],"is":[68,86],"need":[70],"that":[75,597],"combine":[76],"efficacy":[78,143,684],"low":[80],"toxicity.":[81],"Toll-like":[82],"2":[84,433,487,570],"(TLR2)":[85],"expressed":[87],"by":[88,229,267,275,287,299,488],"T-cells,":[89],"its":[91],"engagement":[92],"enhances":[93],"expansion,":[95],"modulates":[96],"production,":[98],"promotes":[100],"long-lived":[101],"memory.":[103],"In":[104,584,640],"preclinical":[105,643],"studies,":[106],"interposition":[107,648],"an":[109],"domain":[111,652],"from":[112,198],"TLR2":[113,157,601,651],"between":[114,653],"CD3\u03b6":[117,656],"resulted":[118],"in":[119,306,342,359,364,407,436,508,558,626],"reduced":[120],"production":[123,132],"ICANS-associated":[125],"cytokines":[126],"GM-CSF":[127],"IFN-\u03b3,":[129],"while":[130,664],"maintaining":[131],"the":[134,140,316,393,681],"homeostatic":[135],"IL-7.":[137],"We":[138,163],"investigated":[139],"safety":[141,682],"novel":[146,591],"third":[147],"generation":[148],"product,":[152],"which":[153],"combines":[154,598],"(":[160],"Figure).":[161],"Methods:":[162],"completed":[164],"first-in-human":[166],"phase":[167,569],"1":[168,204,431,478,577],"dose":[169,191,317,463,493,502,520,571,586,622,670],"escalation":[170,192,318,587],"trial":[171,588],"WZTL-002,":[173],"comprising":[174],"autologous":[175],"1928T2z":[176],"T-cells":[178,246,371,516,556,688],"(\u2018ENABLE\u2019,":[179],"NCT04049513)":[180],"patients":[182,313,390,438],"r/r":[184,605],"non-Hodgkin":[186],"lymphomas":[187],"(B-NHL).":[188],"A":[189,567],"3+3":[190],"design":[193],"was":[194,233,286,322,494,543,581,631],"used,":[195],"doses":[197],"5":[199,473,476],"\u00d7":[200,205,474,479,528,578],"10":[201,206,329,475,480,529,579],"4":[202,333,352,461],"to":[203,485,633,668],"6":[207,440,481,530],"viable":[208],"T-cells/kg":[210,532],"body":[211],"weight.":[212],"Eligible":[213],"participants":[214],"had":[215,347,391],"radiologically":[216],"assessable":[217],"disease,":[218],"satisfactory":[219],"organ":[220],"function":[221],"no":[223,453,609,612],"central":[224],"nervous":[225],"system":[226],"(CNS)":[227],"involvement":[228],"lymphoma.":[230],"Bridging":[231],"therapy":[232],"permitted":[234],"after":[235,250,399],"leukapheresis":[236],"pending":[238],"manufacture":[241],"release.":[243],"WZTL-002":[244,369,400,514,686],"were":[247,265,298,331,337,372,498],"administered":[248],"intravenously":[249],"3":[251,404,444],"days":[252],"fludarabine":[254],"(30mg/m":[255],"2/day)":[256,260],"cyclophosphamide":[258],"(500mg/m":[259],"lymphodepletion.":[261],"Adverse":[262],"events":[263],"(AEs)":[264],"graded":[266],"CTCAE":[268],"5.0":[269],"except":[270],"CRS":[271,434,447],"ICANS":[273,454,613,662],"(graded":[274],"American":[276],"Society":[277],"Transplantation":[279],"Cellular":[281],"Therapy":[282],"criteria).":[283],"Response":[284],"assessment":[285],"PET/CT":[288],"at":[289,467,472,500,511,518,550,564,620],"month":[290,512],"3,":[291,451],"per":[292],"Lugano":[293],"2014":[294],"criteria.":[295],"Pharmacokinetic":[296],"analyses":[297],"droplet":[300],"digital":[301],"PCR":[302],"transgenes":[305],"blood":[307],"mononuclear":[308],"cells.":[309],"Results:":[310],"Of":[311],"21":[312,469],"treated":[314],"within":[315],"trial,":[319],"median":[320,350,373,536,551],"age":[321],"57":[323],"years":[324],"(range":[325],"23":[326],"-":[327,432,526,576],"70);":[328],"(48%)":[330],"female;":[332],"(19%)":[334],"M\u0101ori.":[335],"Lymphomas":[336],"large":[339],"histology":[341],"17":[343],"(81%,":[344],"Table).":[345],"Participants":[346],"received":[348,441],"prior":[353],"lines":[354],"therapy,":[356],"including":[357],"autograft":[358],"11":[360,509,561],"(52%)":[361,510],"allograft":[363],"1.":[365],"Product":[366],"phenotyping":[367],"showed":[368],"49%":[374],"CD4":[375],"+,":[376],"41%":[377],"CD8":[378],"+":[379],"34%":[381],"CD62L":[382],"+.":[383],"As":[384],"June":[386],"14":[387],"2023,":[388],"all":[389,501,519,621],"reached":[392],"primary":[394],"follow-up":[395],"timepoint":[396],"(3":[397],"months":[398],"administration).":[401],"Grade":[402,430],"\u2265":[403,408,450],"AEs":[405],"occurring":[406],"10%":[409],"recipients":[411,523],"were:":[412],"neutropenia":[413,422],"(95%),":[414],"lymphopenia":[415],"(57%),":[416,418],"hypogammaglobulinemia":[417],"anaemia":[419],"(43%),":[420,423],"febrile":[421],"thrombocytopenia":[424],"(24%)":[425],"tumor":[427],"pain":[428],"(19%).":[429],"occurred":[435,466],"13":[437],"(62%);":[439],"tocilizumab":[442],"dexamethasone.":[445],"No":[446],"grade":[449,460,486,616],"any":[456,615],"grade,":[457],"occurred.":[458],"Two":[459],"cytopenia":[462],"limiting":[464],"toxicities":[465],"day":[468,489,552,565],"(one":[470],"each":[471],"cells/kg),":[482],"both":[483],"resolved":[484],"90.":[490,566],"Maximum":[491],"tolerated":[492],"not":[495],"reached.":[496],"Responses":[497],"seen":[499],"levels":[503],"complete":[505,618],"metabolic":[506],"3.":[513],"expanded":[517],"levels.":[521,623],"Among":[522],"0.5":[525,575],"1.0":[527],"(n":[533],"=":[534],"12),":[535],"peak":[537],"level":[540],"(C":[541],"max)":[542],"93,950":[544],"transgene":[545],"copies/\u03bcg":[546],"genomic":[547],"DNA":[548],"(reached":[549],"10)":[553],"persisted":[557],"9":[559],"assessed":[562],"(82%)":[563],"recommended":[568],"(RP2D)":[572],"range":[573],"6/kg":[580],"selected.":[582],"Conclusions:":[583],"this":[585,645],"third-generation":[592],"product":[596],"B-NHL,":[606],"we":[607],"observed":[608],"CRS,":[611],"responses":[619],"At":[624],"RP2D,":[625],"vivo":[627],"expansion":[630,671],"similar":[632],"greater":[635],"other":[637],"conjunction":[641],"findings,":[644],"study":[646],"suggests":[647],"may":[658],"reduce":[659],"T-cell-related":[661],"risk":[663],"retaining":[665],"efficacy.":[666],"Enrolment":[667],"cohort":[672],"has":[673],"commenced":[674],"will":[676],"assess":[677],"outpatient":[678],"management":[679],"manufactured":[689],"using":[690],"closed":[692],"automated":[693],"process.":[694]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2023-12-02T00:00:00"}